Literature DB >> 29985751

Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.

Guihua Tang1, Wen Yin2, Youde Cao1, Liming Tan1, Shuyu Wu2, Yudong Cao2, Xianyong Fu2, Jing Yan3, Xingjun Jiang2.   

Abstract

BACKGROUND: The emergence of vaccine-associated paralytic poliomyelitis has become an ongoing burden of poliomyelitis. During this special period from OPV to IPV-only immunization schedule, we did a meta-analysis to compare the immunogenicity of sequential IPV and OPV versus IPV alone in healthy infants.
METHODS: This systematic review and meta-analysis was registered at international prospective register of systematic reviews (PROSPERO), and the number was CRD42017054889. We performed it as described.
RESULTS: Finally, 6 articles were qualified for our review. The results showed that seroconversion rates against all 3 serotype polioviruses were non-inferior and Geometric mean antibody titers (GMTs) were superior in sequential schedules compared with IPV-only schedule. Thus, the sequential vaccination schedules could induce a stronger immunogenicity.
CONCLUSIONS: To decrease vaccine-associated and vaccine-derived poliomyelitis, it is a reasonable option to select sequential schedules during this special transition from OPV to IPV-only immunization schedule, which coincides with the current WHO recommendations.

Entities:  

Keywords:  Immunogenicity; Inactivated poliovirus vaccines; Oral poliovirus vaccines; sequential schedule; vaccination

Mesh:

Substances:

Year:  2018        PMID: 29985751      PMCID: PMC6314415          DOI: 10.1080/21645515.2018.1489188

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  45 in total

1.  Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013-2016.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-07-03

2.  Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.

Authors:  R W Sutter; A J Suleiman; P G Malankar; F R Mehta; M A Medany; M A Arif; R W Linkins; M A Pallansch; M S El-Bualy; S E Robertson
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.

Authors: 
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 4.  Polio vaccination: past, present and future.

Authors:  Ananda S Bandyopadhyay; Julie Garon; Katherine Seib; Walter A Orenstein
Journal:  Future Microbiol       Date:  2015-03-31       Impact factor: 3.165

5.  Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.

Authors:  H Faden; L Duffy; M Sun; C Shuff
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

Review 6.  Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies.

Authors:  Duncan Chambers; Mark Rodgers; Nerys Woolacott
Journal:  J Clin Epidemiol       Date:  2009-04-05       Impact factor: 6.437

7.  Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.

Authors:  Edwin J Asturias; Ananda S Bandyopadhyay; Steve Self; Luis Rivera; Xavier Saez-Llorens; Eduardo Lopez; Mario Melgar; James T Gaensbauer; William C Weldon; M Steven Oberste; Bhavesh R Borate; Chris Gast; Ralf Clemens; Walter Orenstein; Miguel O'Ryan G; José Jimeno; Sue Ann Costa Clemens; Joel Ward; Ricardo Rüttimann
Journal:  Lancet       Date:  2016-05-19       Impact factor: 79.321

Review 8.  Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.

Authors:  Lauren R Platt; Concepción F Estívariz; Roland W Sutter
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

9.  Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.

Authors:  Mohammadreza Shaghaghi; Shohreh Shahmahmoodi; Hassan Abolhassani; Saeed Soleyman-Jahi; Leila Parvaneh; Sussan Mahmoudi; Zahra Chavoshzadeh; Reza Yazdani; Seyed Mohsen Zahraei; Mohsen Ebrahimi; Mohammad H Eslamian; Hamideh Tabatabaie; Maryam Yousefi; Yaghoob M Kandelousi; Aliasghar Oujaghlou; Nima Rezaei; Asghar Aghamohammadi
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

10.  Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.

Authors:  Mohamed A Sheikh; Frederick Makokha; Abdullahi M Hussein; Gedi Mohamed; Ondrej Mach; Kabir Humayun; Samuel Okiror; Leila Abrar; Orkhan Nasibov; John Burton; Ahmed Unshur; Kathleen Wannemuehler; Concepcion F Estivariz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

View more
  3 in total

1.  Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.

Authors:  Agustín Ciapponi; Ariel Bardach; Lucila Rey Ares; Demián Glujovsky; María Luisa Cafferata; Silvana Cesaroni; Aikant Bhatti
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

2.  Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China.

Authors:  Yuemei Hu; Kangwei Xu; Weixiao Han; Kai Chu; Deyu Jiang; Jianfeng Wang; Xiaohui Tian; Zhifang Ying; Ying Zhang; Changgui Li; Fengcai Zhu
Journal:  Open Forum Infect Dis       Date:  2019-08-26       Impact factor: 3.835

3.  The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy.

Authors:  Shiyi Chen; Yuping Zhao; Zhiyao Yang; Ying Li; Hongyuan Shi; Ting Zhao; Xiaolei Yang; Jing Li; Guoliang Li; Jianfeng Wang; Zhifang Ying; Jingsi Yang
Journal:  Hum Vaccin Immunother       Date:  2022-01-19       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.